Developer of a fusion technology intended to offer technical assistance to accelerate the practical realization of fusion energy. The company's technology offers liquid metal, molten salt, tritium treatment systems, high-frequency microwave gyrotron, fusion energy and exhaust systems, and is focused on developing advanced technologies for commercial fusion reactors, including gyrotron systems, tritium fuel cycle technologies and breeding blankets for tritium production and power generation, enabling companies to eliminate carbon dioxide emissions.
Luca Science Inc. specializes in creating a new treatment using mitochondria, which is bioenergy itself. It is based in Japan.
Cellusion is a regenerative medicine startup from Keio University. The mission of Cellusion is to deliver novel therapies for all bullous keratopathy patients by our iPS cells origin corneal endothelial cells mass culture system.
Rege Nephro Co., Ltd. engages in the research and development, production, and marketing of renal disease therapeutics using nephron progenitor cells. It also produces kidney organoids capable of nephrotoxicity screening for drug discovery in applied research. The company was founded in 2019 and is based in Kyoto, Japan.
Luxonus is engaged in the development of advanced imaging devices utilizing photoacoustic technology. This innovative approach allows for the early detection and diagnosis of diseases by producing ultra-high-resolution three-dimensional images of blood vessels and lymphatic vessels. The device operates safely and effectively without exposing patients to harmful radiation, as it combines optical and ultrasonic waves. By providing detailed insights into the onset of diseases, the healing process, and health conditions before and after illness, Luxonus aims to enhance the diagnostic capabilities available to healthcare professionals.
Koala Tech Inc., founded in 2019 and based in Fukuoka, Japan, is a high-tech startup focused on developing organic semiconductor laser diodes. The company aims to pioneer practical applications of this innovative technology, which was first realized at the Center for Organic Photonics and Electronics Research at Kyushu University. Koala Tech's organic fluorescent semiconductor technology is notable for its ease of processing into thin films, making it less harmful and more efficient. This advancement provides businesses with a low-cost light source that can be seamlessly integrated into OLED and other organic electronic platforms, positioning Koala Tech at the forefront of the organic semiconductor industry.
Alchemedicine is a company focused on drug discovery aimed at addressing diseases with significant unmet medical needs. Utilizing unique technologies and innovative approaches, Alchemedicine develops new drug candidates even in challenging areas where traditional drug discovery may struggle. The company’s services are designed to expedite the process of bringing effective medications to patients, ensuring that new treatments are available as quickly as possible. Through its commitment to advancing medical solutions, Alchemedicine plays a vital role in the fight against diseases that lack adequate therapeutic options.
Aipore Inc. is a technology company based in Shibuya-ku, Tokyo, Japan, specializing in the development of nanopore sensors that leverage semiconductor microfabrication technology. Founded in 2018, the company focuses on creating IoT-based sensors capable of measuring and analyzing changes in ion current to identify fine particles, including nanoparticles and viruses, with high accuracy. Aipore's innovative technology integrates various advancements such as silicon MEMS, flow path surface control, and low noise amplification circuits, along with artificial intelligence to enhance the analysis of transient ion current changes. These sensors have diverse industrial applications, including microorganism identification, laboratory testing, cancer detection, blood diagnostics, livestock inspection, and environmental evaluations, enabling precise measurement of microparticles across different sectors.
MiraBiologics is a biopharmaceutical company focused on developing next-generation multifunctional biopharmaceuticals, known as neobiologics, to address unmet medical needs, particularly in the field of rare diseases. Utilizing its proprietary LassoGraft Technology, the company aims to create innovative treatment modalities that offer effective solutions while reducing the costs associated with traditional medical approaches. By streamlining the drug development process for novel targets, MiraBiologics enables faster and more efficient discovery of bispecific and multispecific agents, contributing to a transformative impact on healthcare and improving patient outcomes.
Cellusion is a regenerative medicine startup from Keio University. The mission of Cellusion is to deliver novel therapies for all bullous keratopathy patients by our iPS cells origin corneal endothelial cells mass culture system.
AceRNA contributes to regenerative medicine and drug discovery through the discovery of novel miRNA functions. It began operation in April 2018, with its headquarters in Kyoto in Japan.
Pixie Dust Technologies, Inc. is a Tokyo-based company that specializes in the development of innovative technologies, particularly in phased array and digital fabrication. Founded in 2015, it has created an ultrasonic phased array system that enables the generation of force in mid-air, allowing for applications such as non-contact transportation of objects, targeted sound delivery among individuals in a crowd, and guidance for service animals. The company also offers various consumer products, including Sound Hug, a device that combines music with light and vibration; Sonorepro, a hair care tool utilizing non-contact oscillating pressure; Vuevo, which visualizes conversations for improved communication; and kikippa, a gamma wave sound care device. Through these technologies, Pixie Dust Technologies aims to enhance user experiences by integrating sound and light into everyday interactions.
Veritas In Silico is a start-up to research and sales of pharmaceuticals.Veritas In Silico, target partial structures in messenger RNA (mRNA) by exploring the true form of RNA, the origin of life, based on in silico (computer-based computational science) technology Established a drug discovery system with a completely new concept.This mRNA-targeted drug has the potential to be applied to any disease, including those for which it has been difficult to develop therapeutic drugs using conventional protein-based drug discovery. Therefore, it is expected to be a favorite for next-generation drug discovery that will cause a paradigm shift in the pharmaceutical industry.
NeuroSpace Co., Ltd., founded in 2013 and based in Tokyo, Japan, specializes in the manufacturing and sale of brain wave-related equipment designed for analyzing sleep patterns. The company operates a sleep analysis platform that enhances users' sleep cycles and promotes overall well-being. Utilizing advanced neuroscience technology, NeuroSpace offers tools for monitoring sleep and addressing jet lag, particularly for travelers. Additionally, the platform provides sleep-related advice aimed at reducing sleep issues and optimizing sleep quality, ultimately enabling users to achieve greater productivity through improved rest.
AlphaNavi Pharma Co., Ltd. is a drug discovery company based in Kyoto, Japan, founded in 2019. The company specializes in developing new pain therapeutics, focusing on voltage-gated sodium channel selective inhibitors. Its primary products, ANP-230 and ANP-231, are designed to address peripheral neuropathic pain. AlphaNavi Pharma collaborates with academic institutions, investors, and patients to advance its research and clinical development efforts, aiming to create innovative analgesic drugs that alleviate suffering and improve the quality of life for patients and their families.
Neural Pocket Inc. is a Tokyo-based company that develops proprietary artificial intelligence technologies aimed at enhancing urban environments and commercial applications. Founded in 2018 and formerly known as Fashion Pocket Inc., the company specializes in AI-driven image and video recognition, offering services that encompass spatial awareness, body movement analysis, and facial expression interpretation. Neural Pocket's solutions are designed for smart city initiatives, addressing mobility, infrastructure, and security needs, as well as facilitating the digitalization of factories, warehouses, and retail settings. Additionally, the company provides digital signage services for advertisers and conducts AI-powered fashion trend analysis by leveraging data from social media and e-commerce platforms.
Innophys Co., Ltd., founded in 2013 and based in Tokyo, Japan, specializes in wearable robotics technology. The company designs, manufactures, and distributes innovative robotics equipment aimed at various industries. Its flagship product, the Muscle Suit®, utilizes artificial muscle technology to provide physical assistance, reducing strain during tasks such as lifting heavy objects or working in bent positions. The Muscle Suit® is recognized for its high quality and competitive pricing compared to other exoskeletons in the market. Innophys aims to expand its reach into the Asia Pacific, European, and North American markets, enhancing the ability of users to perform tasks independently and improve their quality of life.
Ball Wave Inc. specializes in the development, manufacturing, and sale of advanced sensors, including trance moisture sensors, mini sensors, and ball surface acoustic wave gas sensors. Founded in 2015 and based in Sendai, Japan, the company focuses on innovative sensor technology that enables high-speed and sensitive detection of various chemical attributes, such as moisture and hydrogen, at the nanoscale. Their spherical sensors and analyzers serve as essential tools for accurately monitoring environmental conditions, effectively functioning as an advanced detection system for a range of gases and materials.
Braizon Therapeutics, Inc. is a Tokyo-based company focused on the research and development of innovative drug delivery technologies aimed at treating central nervous system disorders. Founded in 2015, the company leverages collaborative research from prominent academics, including Professor Kazunori Kataoka and Professor Takanori Yokota, to create methodologies that facilitate the delivery of therapeutic drugs across the blood-brain barrier. By developing new drugs, diagnostics, and life science reagents, Braizon Therapeutics seeks to address the challenges associated with treating incurable neuronal diseases, ultimately enhancing the effectiveness of therapies for patients suffering from these conditions.
NB Health Laboratory Co. Ltd. is a biotechnology company based in Kawaguchi, Japan, focused on the research and development of innovative drugs primarily targeting respiratory diseases, chronic inflammation, and infectious diseases. The company provides a research platform for screening small compounds in vitro and offers functional monoclonal antibodies. It engages in contract research, co-development, and licensing activities, and has developed DAP Kinase inhibitors aimed at addressing stroke and heart diseases. Additionally, NB Health Laboratory conducts research programs related to chronic obstructive pulmonary disease (COPD), aneurysms, and skin wrinkles, as well as drug and functional monoclonal antibody screening programs. Their products are designed for the treatment of vascular diseases, including atherosclerosis and stroke, as well as other conditions such as diabetes-related vascular disorders, COPD, and sleep disorders.
Meijo Nano Carbon Co., Ltd. is a Japanese company founded in April 2005, stemming from Meijo University, that specializes in the manufacture of carbon nanotube chemicals. The company produces a variety of carbon nanotubes, including single-walled nanotubes and metallic or semiconducting variants, as well as carbon nanotube dispersions in various forms, such as inks. These products are designed to serve as alternatives to traditional conductive materials like copper, offering benefits such as enhanced conductivity and reduced weight. Meijo Nano Carbon's technologies cater to industries including aerospace, automotive, and petrochemicals, providing solutions that enable manufacturers to replace heavier components with their lightweight nanotube products. The company's headquarters is located in Nagoya, Japan.
TAGCyx Biotechnologies is a company focused on developing innovative nucleic acid-based drugs for therapeutic purposes. Founded in 2007 and based in Tokyo, Japan, TAGCyx has established its proprietary Xenoligo technology platform. This platform employs genetic alphabet expansion through unnatural base pairs, allowing for the creation of customized nucleic acids tailored for specific therapeutic applications. By leveraging this advanced technology, TAGCyx aims to enhance drug discovery and facilitate the efficient treatment of various diseases.
AccuRna, Inc. is a biotechnology company based in Tokyo, Japan, founded in 2015. The company specializes in the research and development of nucleic acid-based drugs, focusing on innovative drug delivery system technologies. AccuRna aims to address refractory diseases that currently lack effective treatments by utilizing its advanced drug delivery systems. The company offers two platforms for delivering various types of nucleic acids, including short chain and long chain RNA, which encompass siRNA, ASO, miRNA, mRNA, and CRISPR-Cas. Through these technologies, AccuRna seeks to provide safe and efficient therapeutic solutions for patients suffering from challenging medical conditions.
NeuroSpace Co., Ltd., founded in 2013 and based in Tokyo, Japan, specializes in the manufacturing and sale of brain wave-related equipment designed for analyzing sleep patterns. The company operates a sleep analysis platform that enhances users' sleep cycles and promotes overall well-being. Utilizing advanced neuroscience technology, NeuroSpace offers tools for monitoring sleep and addressing jet lag, particularly for travelers. Additionally, the platform provides sleep-related advice aimed at reducing sleep issues and optimizing sleep quality, ultimately enabling users to achieve greater productivity through improved rest.
Stem Cell & Device Laboratory, Inc. focuses on research and development, manufacturing, and sales of cellular products, devices, and integrated cell-material products specifically designed for drug discovery applications. The company specializes in creating innovative scaffold materials that enhance cell functionality and compatibility, leveraging advanced micro-engineering and nanofabrication technologies. Founded in 2014 and headquartered in Kyoto, Japan, Stem Cell & Device Laboratory is dedicated to advancing cell applications that contribute to a healthier society.
NIL is a company developed innovative functional ultrafine particle technology based on many years of research experience.
Spectronics is a development of new technologies and new applications to bring about innovation, focusing on the future of laser technology.
QD Laser, Inc. is a manufacturer of quantum dot semiconductor lasers and wafers, utilizing GaAs substrate for various applications in communications and industry. The company produces a range of products, including picosecond short-pulse DFB lasers for precision processing, current injection-type lasers in green, yellow-green, and orange for biological sciences, and quantum dot laser arrays for silicon optical circuits. Additionally, it offers broadband gain chips for ophthalmic testing equipment and retinal imaging laser eyewear. QD Laser's technology is applied in areas such as silicon photonics, sensing, and precision machining. The company serves a diverse clientele across telecommunications, manufacturing, medicine, and consumer products. Established in 2006, QD Laser is headquartered in Kawasaki, Japan.
Ball Wave Inc. specializes in the development, manufacturing, and sale of advanced sensors, including trance moisture sensors, mini sensors, and ball surface acoustic wave gas sensors. Founded in 2015 and based in Sendai, Japan, the company focuses on innovative sensor technology that enables high-speed and sensitive detection of various chemical attributes, such as moisture and hydrogen, at the nanoscale. Their spherical sensors and analyzers serve as essential tools for accurately monitoring environmental conditions, effectively functioning as an advanced detection system for a range of gases and materials.
TAGCyx Biotechnologies is a company focused on developing innovative nucleic acid-based drugs for therapeutic purposes. Founded in 2007 and based in Tokyo, Japan, TAGCyx has established its proprietary Xenoligo technology platform. This platform employs genetic alphabet expansion through unnatural base pairs, allowing for the creation of customized nucleic acids tailored for specific therapeutic applications. By leveraging this advanced technology, TAGCyx aims to enhance drug discovery and facilitate the efficient treatment of various diseases.
Neuroceuticals Inc. manufactures medical devices. The company offers products, such as a video endoscope system, vagal nerve stimulation catheter system, temperature monitoring monitor catheter, and medical pen blade. Neuroceuticals Inc. was founded in 2009 and is based in Tokyo, Japan.
Chromocenter Inc. is a biopharmaceutical company based in Yonago, Japan, founded in 2005. The company specializes in the development of artificial chromosome technologies, which are utilized primarily for life sciences applications. By employing artificial chromosome vectors, Chromocenter focuses on advancing drug discovery processes, particularly in the field of medical pharmaceuticals. Its innovative approach aims to enhance the efficacy and efficiency of biopharmaceutical manufacturing, positioning the company at the forefront of next-generation therapeutic development.
Atonarp Inc. is a scientific instrumentation company that specializes in designing and manufacturing advanced tools for molecular analysis. The company offers the AMS 1000, a cloud-connected and AI-enabled mass spectrometer that enables real-time quantitative analysis of chemical processes. Additionally, Atonarp provides the LyoSentinel, a miniaturized mass spectrometer designed for gas detection in lyophilization processes. These instruments are utilized across various industries, including pharmaceuticals and semiconductors, to monitor critical parameters such as vacuum integrity, contamination, and gas composition, enhancing efficiency and compliance. Atonarp is also developing a Smart Spectrometer platform aimed at improving gas-composition analysis, targeting applications in healthcare and oil and gas industries. Founded in 2009, Atonarp is headquartered in Tokyo, Japan, with additional offices in Fremont, California, and Bengaluru, India.
Nanophoton Corporation specializes in the research, development, manufacture, and sale of advanced laser microscopy products. The company offers a range of instruments, including laser Raman microscopes, wide field Raman scopes, and tip-enhanced Raman microscopes. Additionally, it provides specialized equipment such as closed vessels for Raman spectroscopy of lithium-ion batteries, Z polarizers for three-dimensional measurements, and laser speckle reducers for enhanced microscope illumination. These products serve various industries, including semiconductors, secondary batteries, carbon materials, inorganic compounds, polymers, pharmaceuticals, and food applications. Nanophoton distributes its products globally through a network of representatives and distributors. Founded in 2003, the company is headquartered in Osaka, Japan.
Stem Cell & Device Laboratory, Inc. focuses on research and development, manufacturing, and sales of cellular products, devices, and integrated cell-material products specifically designed for drug discovery applications. The company specializes in creating innovative scaffold materials that enhance cell functionality and compatibility, leveraging advanced micro-engineering and nanofabrication technologies. Founded in 2014 and headquartered in Kyoto, Japan, Stem Cell & Device Laboratory is dedicated to advancing cell applications that contribute to a healthier society.
Normee Limited specializes in palm recognition technology that utilizes the built-in cameras of smartphones and tablets to identify users based on their unique palm patterns, including lines, ridges, veins, and capillaries. Founded on February 1, 2005, and headquartered in Tokyo, Japan, Normee's innovative system allows for accurate palm vein authentication using standard visible-spectrum cameras. This technology enables clients to adopt hybrid biometric authentication tailored to their specific operating environments, enhancing security and user experience. Normee was previously known as Universal Robot Co., Ltd.
BONAC Corporation focuses on the research, development, manufacturing, and commercialization of nucleic acid pharmaceutical products, utilizing advanced nucleic acid platform technology. Established in 2010 and headquartered in Kurume, Japan, with an office in Tokyo, the company specializes in the production and sale of nucleic acid ingredients. BONAC offers a comprehensive suite of services that includes drug substance manufacturing and support for drug development, aiming to facilitate access to innovative drug substances for pharmaceutical and cosmetic manufacturers. Through its efforts, BONAC addresses unmet medical needs by advancing RNA technology and developing effective nucleic acid medicines.
Nanoegg is aiming to create a medical breakthrough from skin research and to realize medical care without the use of needles.
FLOSFIA INC. is a Tokyo-based company that specializes in the development of corundum structured Gallium Oxide semiconductor power devices. Founded on March 31, 2011, the firm emerged as a spin-off from research conducted at Kyoto University. FLOSFIA focuses on utilizing the unique physical properties of gallium oxide to create low-loss power devices that offer high breakdown voltage and efficiency. The company employs mist chemical vapor deposition (CVD) techniques for film formation, which enhances the performance of its semiconductor products.
QD Laser, Inc. is a manufacturer of quantum dot semiconductor lasers and wafers, utilizing GaAs substrate for various applications in communications and industry. The company produces a range of products, including picosecond short-pulse DFB lasers for precision processing, current injection-type lasers in green, yellow-green, and orange for biological sciences, and quantum dot laser arrays for silicon optical circuits. Additionally, it offers broadband gain chips for ophthalmic testing equipment and retinal imaging laser eyewear. QD Laser's technology is applied in areas such as silicon photonics, sensing, and precision machining. The company serves a diverse clientele across telecommunications, manufacturing, medicine, and consumer products. Established in 2006, QD Laser is headquartered in Kawasaki, Japan.
SanBio Company Limited is a regenerative medicine firm based in Tokyo, Japan, focused on developing and commercializing cell-based therapies for various central nervous system disorders. The company is advancing its lead product, SB623, currently in Phase II clinical trials for treating chronic motor deficits caused by traumatic brain injury and stroke. SanBio's research pipeline also includes SB618 for peripheral nerve damage, SB308 for muscular dystrophy, and other products targeting conditions such as age-related macular degeneration, retinitis pigmentosa, Parkinson’s disease, spinal cord injuries, and Alzheimer’s disease. Collaborations with several academic institutions and partners, such as Asahikawa Medical University and Juntendo University, support the development of these therapies. Founded in 2001, SanBio aims to address unmet medical needs through innovative regenerative medicine solutions.
Normee Limited specializes in palm recognition technology that utilizes the built-in cameras of smartphones and tablets to identify users based on their unique palm patterns, including lines, ridges, veins, and capillaries. Founded on February 1, 2005, and headquartered in Tokyo, Japan, Normee's innovative system allows for accurate palm vein authentication using standard visible-spectrum cameras. This technology enables clients to adopt hybrid biometric authentication tailored to their specific operating environments, enhancing security and user experience. Normee was previously known as Universal Robot Co., Ltd.
UniZeo Co., Ltd. is a Tokyo-based company that focuses on the research, development, manufacturing, and sales of zeolite and silica products, along with related catalysts and adsorption solutions. Established in 2013, UniZeo produces synthetic zeolite, a microporous mineral that has diverse applications across various sectors. Its products are utilized in water purification, as catalysts in the petrochemical industry, as cement additives in construction, and in the formulation of laundry detergents. This versatility allows UniZeo to serve clients in medical and agricultural fields, offering effective solutions tailored to their specific needs.